Nonoperative assessment of nodal status for locally advanced cervical squamous cell carcinoma treated by radiotherapy with regard to patterns of treatment failure

International Journal of Radiation Oncology Biology Physics

Volumn 55, Issue 2, 2003, Pages 354-361

  Ohara, Kiyoshi ^a,b   Tanaka, Yumiko Oishi ^a   Tsunoda, Hajime ^a   Sugahara, Shinji ^a   Hashimoto, Takayuki ^a   Kagei, Kenji ^a   Tokuuye, Koichi ^a   Akine, Yasuyuki ^a   Yoshikawa, Hiroyuki ^a   Itai, Yuji ^a  

^a UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Chemoradiotherapy; Para aortic lymph node; Standard treatment; Tumor bulk

Indexed keywords

CELLS; COMPUTERIZED TOMOGRAPHY; PATIENT TREATMENT; TUMORS;

PROGONOSTIC FACTORS;

RADIOTHERAPY;

CISPLATIN; IFOSFAMIDE; NEDAPLATIN; PEPLEOMYCIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PELVIS; SURVIVAL RATE; TREATMENT FAILURE; UTERINE CERVICAL NEOPLASMS;

EID: 0347927350     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)03930-5     Document Type: Article

References (25)

1. Heller P.B., Maletano J.H., Bundy B.N., et al. Clinical-pathologic study of stage IIB, III, and IVA carcinoma of the cervix Extended diagnostic evaluation for paraaortic node metastasis - a Gynecology Oncology Group study . Gynecol Oncol. 38:1990;425-430.
2. Delgado G., Bundy B., Zaino R., et al. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix A Gynecology Oncology Group study . Gynecol Oncol. 38:1990;352-357.
3. Lanciano R.M., Won M., Hanks G.E. A reappraisal of the International Federation of Gynecology and Obstetrics staging system for cervical cancer A study of patterns of care . Cancer. 69:1992;482-487.
4. Perez C.A., Grigsby P.W., Nene S.M., et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer. 69:1992;2796-2806.
5. Eifel P.J., Morris M., Wharton J.T., et al. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 29:1994;9-16.
6. Toita T., Nakano M., Higashi M., et al. Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for patients with uterine cervical cancer treated by radical radiation therapy. Int J Radiat Oncol Biol Phys. 33:1995;843-849.
7. Sevin B.U., Lu Y., Bloch D.A., et al. Surgically defined prognostic parameters in patients with early cervical carcinoma A multivariate survival tree analysis . Cancer. 78:1996;1438-1446.
8. Barillot I., Horiot J.C., Pigneux J., et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone A French cooperative study - Update and multivariate analysis of prognostics factors . Int J Radiat Oncol Biol Phys. 38:1997;969-978.
9. Cervical Cancer (PDQ). treatment. 2002;. Available at http://www.cancer.gov/cancer_information/. Accessed May.
10. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 340:1999;1137-1143.
11. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 340:1999;1144-1153.
12. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes A Gynecology Oncology Group and Southwest Oncology Group study . J Clin Oncol. 17:1999;1339-1348.
13. Hricak H., Yu K.K. Radiology in invasive cervical cancer. AJR Am J Roentgenol. 167:1996;1101-1108.
14. Vinnicombe S.J., Norman A.R., Nicolson V., et al. Normal pelvic lymph nodes Evaluation with CT after bipedal lymphangiography . Radiology. 194:1995;349-355.
15. Inoue T., Chihara T., Morita K. The prognostic significance of the size of the largest nodes in metastatic carcinoma from the uterine cervix. Gynecol Oncol. 19:1984;187-193.
16. Cosin J.A., Fowler J.M., Chen M.D., et al. Pretreatment surgical staging of patients with cervical carcinoma The case for lymph node debulking . Cancer. 82:1998;2241-2248.
17. Goff B.A., Muntz H.G., Paley P.J., et al. Impact of surgical staging in women with locally advanced cervical cancer. Gynecol Oncol. 74:1999;436-442.
18. Grigsby P.W., Siegel B.A., Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol. 19:2001;3745-3749.
19. Williams A.D., Cousins C., Soutter W.P., et al. Detection of pelvic lymph node metastases in gynecologic malignancy A comparison of CT, MR imaging, and positron emission tomography . AJR Am J Roentgenol. 177:2001;343-348.
20. Staging announcement FIGO staging of gynecologic cancers . Int J Gynecol Cancer. 5:1995;319.
21. Alvarez R.D., Potter M.E., Soong S.J., et al. Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage IB cervical cancer patients. Gynecol Oncol. 43:1991;108-112.
22. Yuan C., Wang P., Lai C., et al. Recurrence and survival analyses of 1,115 cervical cancer patients treated with radical hysterectomy. Gynecol Obstet Invest. 47:1999;127-132.
23. Toita T., Kakinohana Y., Shinzato S., et al. Tumor diameter/volume and pelvic node status assessed by magnetic resonance imaging (MRI) for uterine cervical cancer treated with irradiation. Int J Radiat Oncol Biol Phys. 43:1999;777-782.
24. Kodaira T., Fuwa N., Kamata M., et al. Clinical assessment by MRI for patients with stage II cervical carcinoma treated by radiation alone in multicenter analysis Are all patients with stage II disease suitable candidates for chemoradiotherapy? Int J Radiat Oncol Biol Phys. 52:2002;627-636.
25. Ogino I., Okamoto N., Andoh K., et al. Analysis of prognostic factors in stage IIB-IVA cervical carcinoma treated with radiation therapy Value of computed tomography . Int J Radiat Oncol Biol Phys. 37:1997;1071-1077.